Biosimilar Insights
-
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
4/14/2024
This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical Officer at ImmunityBio, gives us a long look behind the curtain at the commercial preparations the company is making as its lead Phase 3 candidate, Anktiva, nears the goal line in non-muscle invasive bladder cancer (NMIBC).
-
Nucleic Acid Therapeutics And Environmental Impact
4/11/2024
Nucleic acid therapeutics offer exciting new avenues of treatment. Learn about the history of nucleic acid therapeutics and the environmental impact of manufacturing mRNA and oligonucleotides.
-
Simplifying CHO Cell Line Genetic Stability Testing
4/11/2024
Here, we describe the use of whole genome sequencing to perform a comprehensive assessment of genetic stability in clonally derived CHO cell banks using the Aptegra™ CHO genetic stability assay.
-
A Single, Comprehensive Method For Genetic Stability Testing
4/11/2024
Discover a genetic stability assay that is fully validated to GMP quality standards and outperforms traditional testing methods with its enhanced speed and accuracy.
-
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.
4/10/2024
Ampersand Biomedicines CEO Jason Gardner, Ph.D. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with the Flagship Pioneering-backed Ampersand, he's putting all those hard-fought lessons to good use.
-
The Smart, Savvy Science Driving Viral Vector Scale-Up
4/8/2024
Learn about cutting-edge strategies, including alternatives to plasmid-based transient transfection, aimed at addressing current process challenges and bringing revolutionary treatments to patients in need.
-
Leveraging Perfusion Early In Process Development For Better Commercial Outcomes
4/5/2024
By addressing the complex needs of cell culture from the start, organizations can take steps to optimize their process, ensuring they are maximizing productivity and product quality.
-
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
3/31/2024
We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode, Karen's thoughtful perspective on the sometimes tumultuous Alzheimer's therapeutics space is valuable to any drug developer working in the cognitive medicines arena.
-
A Cutting-Edge Application To Optimize Cell Preparation And Isolation
3/27/2024
Optimize your cell preparation and isolation process with the cutting-edge MagnetSelect application, designed to work with fresh or thawed apheresis products.
-
A Solution To Automate Concentration, Washing, And Medium Exchange
3/27/2024
Experience the assurance and peace of mind that come from utilizing a solution crafted to support the optimization and reliability of your operations.